Link to this page
Experimental Conditions Ontology
Last uploaded:
November 25, 2024
Jump to:
| Preferred Name | liraglutide | |
| Synonyms |
Victoza Saxenda NN-2211 |
|
| Definitions |
Any condition in which the main influencing factor is liraglutide, a lipopeptide that is an analogue of human GLP-1 and an agonist of the GLP-1 receptor. Liraglutide is used as a hypoglycemic agent and supplemental therapy in the treatment of diabetes mellitus. |
|
| ID |
http://purl.obolibrary.org/obo/XCO_0000907 |
|
| created_by |
slaulede
|
|
| creation_date |
2021-10-15T10:42:36Z
|
|
| database_cross_reference |
PMID:29976929
|
|
| definition |
Any condition in which the main influencing factor is liraglutide, a lipopeptide that is an analogue of human GLP-1 and an agonist of the GLP-1 receptor. Liraglutide is used as a hypoglycemic agent and supplemental therapy in the treatment of diabetes mellitus.
|
|
| has_exact_synonym |
Victoza Saxenda NN-2211
|
|
| has_obo_namespace |
experimental_condition_ontology
|
|
| id |
XCO:0000907
|
|
| label |
liraglutide
|
|
| notation |
XCO:0000907
|
|
| prefLabel |
liraglutide
|
|
| treeView | ||
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping